PORTEX UNIPERC PERCUTANEOUS DILATION TRACHEOSTOMY KIT

K083031 · Smiths Medical Asd, Inc. · BTO · Aug 18, 2009 · Anesthesiology

Device Facts

Record IDK083031
Device NamePORTEX UNIPERC PERCUTANEOUS DILATION TRACHEOSTOMY KIT
ApplicantSmiths Medical Asd, Inc.
Product CodeBTO · Anesthesiology
Decision DateAug 18, 2009
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 868.5800
Device ClassClass 2
AttributesTherapeutic

Intended Use

The kits are intended for use in a controlled setting such as an Intensive Care Unit or operating room with the assistance of trained personnel. A minimum of 2 operators are required – one to maintain the patient's airway, anaesthesia, fibreoptic bronchoscopy, breathing and circulation, and one to perform the procedure.

Device Story

UniPerc™ kit facilitates percutaneous tracheostomy in patients with large neck mass/increased skin-to-trachea depth. Components include extra-length, wire-reinforced, pre-curved, cuffed/uncuffed tracheostomy tube with adjustable flange, inner cannula, obturators, and dilators. Device utilizes Seldinger guidewire dilation technique for insertion. Used in controlled settings (ICU/OR) by trained personnel (minimum two operators: one for airway/anesthesia/bronchoscopy, one for procedure). Adjustable flange accommodates anatomy where standard tubes are too short. Provides secure airway access; benefits patients requiring long-term ventilation or airway management who present with challenging neck anatomy.

Clinical Evidence

No clinical data provided. Substantial equivalence is based on technological characteristics, materials, and design comparisons to legally marketed predicate devices.

Technological Characteristics

Extra-length, wire-reinforced, pre-curved tracheostomy tube with adjustable flange. Includes graduated single-stage dilator with hydrophilic coating. Materials consistent with predicate Portex kits. Sterilization and packaging processes match predicates. Device is a mechanical airway management kit; no electronic or software components.

Indications for Use

Indicated for controlled, elective subcricoid percutaneous insertion of an adjustable flange tracheostomy tube for airway management in patients with large necks and pre-tracheal soft tissue depth exceeding standard tracheostomy tube lengths (up to 50mm). For single use; maximum duration 29 days.

Regulatory Classification

Identification

A tracheostomy tube and tube cuff is a device intended to be placed into a surgical opening of the trachea to facilitate ventilation to the lungs. The cuff may be a separate or integral part of the tracheostomy tube and is, when inflated, intended to establish a seal between the tracheal wall and the tracheostomy tube. The cuff is used to prevent the patient's aspiration of substances, such as blood or vomit, or to provide a means for positive-pressure ventilation of the patient. This device is made of either stainless steel or plastic.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ R083031 ## SECTION 5: 510(k) SUMMARY . | | SECTION 5:<br>510(k) SUMMARY | AUG 1 8 2009 | |----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------| | Trade Name: | Portex® UniPerc™ Percutaneous Dilation Tracheostomy Kit | | | Common Name: | Percutaneous Tracheostomy Kit | | | Classification Name: | Tracheostomy tube and tube cuff (21 CFR 888.5800, Product Code JOH) | | | Contact Person: | John Tullet<br>Regulatory Affairs Manager (International)<br>Smiths Medical | | | | Tel.: +44 (0) 1303 236 815 (ex3202)<br>Fax: +44 (0) 1303 264679 | | | Equivalent to: | Portex® Percutaneous Dilation Tracheostomy Kit with Serial Dilators<br>(K040014)<br>Portex® Percutaneous (GWDF) Tracheostomy Kit (K060945)<br>Portex® UltraPerc Tracheostomy kits (K041348)<br>Smiths Point-Lok Device (K946289)<br>Portex® Blue Line Ultra Tracheostomy tubes (K030381)<br>Portex® Adjustable Flange Tracheostomy Tube (K962175)<br>Portex® Reinforced Tracheal Tubes Cuffed and Uncuffed (K032112)<br>Kapitex Inner Cannula Cleaning Swabs (Class 1 exempt) | | | Device Description: | The UniPerc™ device has been designed to facilitate percutaneous<br>tracheostomy in patients with a large neck mass and a consequently large<br>skin to anterior trachea depth. The UniPerc™ device is centered on an extra<br>length, wire reinforced, pre-curved, cuffed or uncuffed, tracheostomy tube<br>mounted with an adjustable flange. The tube is supplied with an inner<br>cannula, which can be used to line the internal surface of the tube.<br>Obturators, dilators and other parts are supplied with the various kits.<br><br>The UniPerc™ device is designed for insertion using existing, dilating<br>percutaneous or surgical insertion techniques. Care of the device whilst in<br>use also follows existing standards techniques. | | | Intended Use: | The kits are intended for use in a controlled setting such as an Intensive<br>Care Unit or operating room with the assistance of trained personnel. A<br>minimum of 2 operators are required – one to maintain the patient's<br>airway, anaesthesia, fibreoptic bronchoscopy, breathing and circulation,<br>and one to perform the procedure. | | {1}------------------------------------------------ The graduated single stage dilator has a lubricious hydrophilic coating when wetted, to improve its ease of insertion. ## Substantial Equivalence: The Portex® UniPerc™ Percutaneous Dilation Tracheostomy Kit has the same intended use as the Portex UltraPerc Tracheostomy Kits. The Portex® UniPerc™ Percutaneous Dilation Tracheostomy Kit is composed essentially of the same materials as the predicate Portex Limited kits and tubes listed in the predicate device section. The Portex® UniPerc™ Percutaneous Dilation Tracheostomy Kit incorporates a number of design and performance characteristics from the Portex® UltraPerc™ Tracheostomy Kits, the Portex® Percutaneous Tracheostomy Tube kits and the Portex® Adjustable Flange Tracheostomy Tube, including similar sterilization and packaging processes. The determination of substantial equivalence of the Portex® UniPerc™ Percutaneous Dilation Tracheostomy Kit to the predicate devices was based on a comparison of device technological characteristics, intended use and materials of composition. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows a logo for the Department of Health & Human Services. The logo consists of a stylized eagle with three stripes representing the department's mission to protect the health of all Americans and provide essential human services. The text "DEPARTMENT OF HEALTH & HS" is arranged in a circular fashion around the left side of the eagle. Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002 Smiths Medical ASD, Incorporated C/O Mr. John Tullet Regulatory Affairs Manager Smiths Medical International, Limited Boundary Road Hythe, Kent UNITED KINGDOM CT216JN AUG 1 8 2009 Re: K083031 Trade/Device Name: Portex® UniPerc™ Percutaneous Dilation Tracheostomy Kit Regulation Number: 21 CEFR 868 5800 Regulation Number: 21 CFR 868.5800 Regulation Name: Tracheostomy Tube and Tube Cuff Regulatory Class: II Product Code: BTO Dated: August 7, 2009 Received: August 14, 2009 Dear Mr. Tullett: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent to market the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Devices marks. Amendments, or to devices that have been health and Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a provisions of approval application (PMA) . You moveth . . . . . . . . . . . . . . . . . . . . approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ ## Page 2- Mr. Tullett Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Fequirement You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrb/imdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Susan Pinner Susan Runner, D.D.S., M.A. Acting Division Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## SECTION 4: INDICATIONS FOR USE STATEMENT 510(k) Number (if known): |< 0 8 3 0 3 | Device Name: Portex® UniPerc™ Percutaneous Dilation Tracheostomy Kit. Indication For Use: Portex ® UniPerc™ single use Percutaneous Dilation Tracheostomy (PDT) Kits allows the controlled, elective subcricoid perculaneous insertion of an adjustable flange tracheostomy tube for airway management using a Seldings guidewire dilation technique in patients with a large neck and manimum of 50mm of pre-tracheal soft tissue in to the trachea) where standard (up to a maximum of S0mm of pre-tracheal soft tissue anterior to the trached on go noon anatomy (up to a maximum of pre-traches to the trachea) where standard length flange tracheostomy tubes are too short. Tracheostomy tube maximum period of use 29 days. L. Schutte (Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices 510(k) Number: k083031 Prescription Use X (Per 21 CFR 801 Subpart D) AND/ OR Over-The-Counter Use (Per 21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...